Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Trial ID or NCT#

NCT00482352

Status

not recruiting iconNOT RECRUITING

Purpose

This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.

Official Title

Classification Of Acute Lymphoblastic Leukemia

Eligibility Criteria

Ages Eligible for Study: 1 Year to 30 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Neyssa Marina

Contact us to find out if this trial is right for you.

Contact

Peds Hem/Onc CRAs
650-723-5535